Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2015

01-01-2015 | Endocrine Tumors

The Use of Modified Four-Dimensional Computed Tomography in Patients with Primary Hyperparathyroidism: An Argument for the Abandonment of Routine Sestamibi Single-Positron Emission Computed Tomography (SPECT)

Authors: Moshim Kukar, MD, Timothy A. Platz, DO, Timothy J. Schaffner, MD, Rania Elmarzouky, MD, Adrienne Groman, MS, Shicha Kumar, MD, Ahmed Abdelhalim, MD, William G. Cance, MD

Published in: Annals of Surgical Oncology | Issue 1/2015

Login to get access

Abstract

Background

Four-dimensional computed tomography (4D CT) has emerged as an extremely sensitive preoperative imaging modality for primary hyperparathyroidism compared with the historical use of sestamibi and ultrasound (US). Specialized volume rendering and technical modifications further enhance this technique for operative guidance while reducing radiation exposure.

Methods

Patients undergoing parathyroidectomy for primary hyperparathyroidism from December 2010 to September 2013, carried out by two surgeons at a tertiary cancer center, were evaluated. Comparison was made between the three imaging modalities (4D CT, sestamibi, and US) for preoperative localization rate and accuracy. Biochemical parameters and radiation exposure were also analyzed.

Results

A total of 202 patients were identified from the database and 200 patients were included in the analysis. All patients underwent 4D CT (100 %), 185 sestamibi (92.5 %) and 186 US (93 %). In patients with single-gland disease (n = 153), 4D CT, sestamibi, and US were positive in 96 %, 65.4 % and 57.7 % of patients, respectively and, when positive, were accurately localized in 97.2 %, 93.4 % and 96.3 % of patients, respectively. In patients with multigland disease (MGD) [n = 47], 4D CT, sestamibi, and US predicted MGD in 32 %, 0 %, and 13.6 % of patients, respectively. With our technique modification, radiation exposure from 4D CT approached that of sestamibi.

Conclusions

Low-dose, modified 4D CT with volume rendering when compared with sestamibi has a statistically significant higher positivity rate, improved accuracy rate, provides excellent images, superior surgical planning, and has a comparable radiation exposure risk profile. Consideration should be made for the abandonment of routine sestamibi single-positron emission computed tomography (SPECT), with 4D CT as the preoperative imaging modality of choice.
Literature
1.
go back to reference Eichhorn-Wharry LI, Carlin AM, Talpos GB. Mild hypercalcemia: an indication to select 4-dimensional computed tomography scan for preoperative localization of parathyroid adenomas. Am J Surg. 2011:201:334-338.PubMedCrossRef Eichhorn-Wharry LI, Carlin AM, Talpos GB. Mild hypercalcemia: an indication to select 4-dimensional computed tomography scan for preoperative localization of parathyroid adenomas. Am J Surg. 2011:201:334-338.PubMedCrossRef
2.
go back to reference Mortenson MM, Evans DB, Lee JE, et. al. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg. 2008:206:888-895.PubMedCrossRef Mortenson MM, Evans DB, Lee JE, et. al. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg. 2008:206:888-895.PubMedCrossRef
3.
go back to reference Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012:19:577-583.PubMedCrossRef Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012:19:577-583.PubMedCrossRef
4.
go back to reference Starker LF, Mahajan A, Björklund P, Sze G, Udelsman R, Carling T. 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol. 2011:18:1723-1728.PubMedCrossRef Starker LF, Mahajan A, Björklund P, Sze G, Udelsman R, Carling T. 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol. 2011:18:1723-1728.PubMedCrossRef
5.
go back to reference Rodgers SE, Hunter GJ, Hamberg LM, et. al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006:140:932-941.PubMedCrossRef Rodgers SE, Hunter GJ, Hamberg LM, et. al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006:140:932-941.PubMedCrossRef
6.
go back to reference Glynn N, Lynn N, Donagh C, et. al. The utility of 99 mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism. Ir J Med Sci. 2011:180:191-194.PubMedCrossRef Glynn N, Lynn N, Donagh C, et. al. The utility of 99 mTc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism. Ir J Med Sci. 2011:180:191-194.PubMedCrossRef
7.
go back to reference Witteveen JE, Kievit J, Stokkel MPM, Morreau H, Romijn JA, Hamdy NAT. Limitations of Tc99 m-MIBI-SPECT imaging scans in persistent primary hyperparathyroidism. World J Surg. 2011:35:128-139.PubMedCentralPubMedCrossRef Witteveen JE, Kievit J, Stokkel MPM, Morreau H, Romijn JA, Hamdy NAT. Limitations of Tc99 m-MIBI-SPECT imaging scans in persistent primary hyperparathyroidism. World J Surg. 2011:35:128-139.PubMedCentralPubMedCrossRef
8.
go back to reference Gómez-Ramírez J, Sancho-Insenser JJ, Pereira JA, Jimeno J, Munné A, Sitges-Serra A. Impact of thyroid nodular disease on 99 mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism. Langenbecks Arch Surg. 2010:395:929-933.PubMedCrossRef Gómez-Ramírez J, Sancho-Insenser JJ, Pereira JA, Jimeno J, Munné A, Sitges-Serra A. Impact of thyroid nodular disease on 99 mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism. Langenbecks Arch Surg. 2010:395:929-933.PubMedCrossRef
9.
go back to reference Swanson TW, Chan SK, Jones SJ et. al. Determinants of Tc-99 m sestamibi SPECT scan sensitivity in primary hyperparathyroidism. Am J Surg. 2010:199:614-620.PubMedCrossRef Swanson TW, Chan SK, Jones SJ et. al. Determinants of Tc-99 m sestamibi SPECT scan sensitivity in primary hyperparathyroidism. Am J Surg. 2010:199:614-620.PubMedCrossRef
10.
go back to reference Thomas DL, Bartel T, Menda Y, Howe J, Graham MM, Juweid ME. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99 m sestamibi parathyroid scintigraphy. Clin Nucl Med. 2009:34:651-655.PubMedCrossRef Thomas DL, Bartel T, Menda Y, Howe J, Graham MM, Juweid ME. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99 m sestamibi parathyroid scintigraphy. Clin Nucl Med. 2009:34:651-655.PubMedCrossRef
11.
go back to reference Hunter GJ, Schellingerhout D, Vu TH, Perrier ND, Hamberg LM. Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology. 2012:264:789-795.PubMedCrossRef Hunter GJ, Schellingerhout D, Vu TH, Perrier ND, Hamberg LM. Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology. 2012:264:789-795.PubMedCrossRef
14.
go back to reference Lubitz CC, Stephen AE, Hodin RA, Pandharipande P. Preoperative localization strategies for primary hyperparathyroidism: an economic analysis. Ann Surg Oncol. 2012:19:4202-4209.PubMedCentralPubMedCrossRef Lubitz CC, Stephen AE, Hodin RA, Pandharipande P. Preoperative localization strategies for primary hyperparathyroidism: an economic analysis. Ann Surg Oncol. 2012:19:4202-4209.PubMedCentralPubMedCrossRef
15.
go back to reference Vignali E, Picone A, Materazzi G, et. al. A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases. Eur J Endocrinol. 2002:146:783-788.PubMedCrossRef Vignali E, Picone A, Materazzi G, et. al. A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases. Eur J Endocrinol. 2002:146:783-788.PubMedCrossRef
16.
go back to reference Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005:138:583-590.PubMedCrossRef Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005:138:583-590.PubMedCrossRef
Metadata
Title
The Use of Modified Four-Dimensional Computed Tomography in Patients with Primary Hyperparathyroidism: An Argument for the Abandonment of Routine Sestamibi Single-Positron Emission Computed Tomography (SPECT)
Authors
Moshim Kukar, MD
Timothy A. Platz, DO
Timothy J. Schaffner, MD
Rania Elmarzouky, MD
Adrienne Groman, MS
Shicha Kumar, MD
Ahmed Abdelhalim, MD
William G. Cance, MD
Publication date
01-01-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 1/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3940-y

Other articles of this Issue 1/2015

Annals of Surgical Oncology 1/2015 Go to the issue